Study of artery conditions of 'at-risk' Asian people not on lipid-lowering drugs - CIMT
Study identifier:D3560L00092
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Prevalence of atherosclerotic disease in Asian subjects not on lipid-lowering agents, but with at least two CVD risk factors
Medical condition
cardiovascular disease
Phase
N/A
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
2609
Study type
Interventional
Age
30 Years - 69 Years
Date
Study Start Date: 01 Oct 2009
Primary Completion Date: 01 Aug 2010
Study Completion Date: 01 Aug 2010
Study design
Allocation: N/A
Endpoint Classification: N/A
Intervention Model: Single Group Assignment
Masking: None
Primary Purpose: Screening
Verification:
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| Experimental: 1 | Procedure/Surgery: Measurement of the Carotid Intima Media thickness one time, radiological procedure on both sides of the neck Biological/Vaccine: Blood sample testing for hs-CRP one time, blood sample taking |
Contacts
Investigators
Principal Investigator
Guy Yeoman
Asia Pacific Regional Office, AstraZeneca Singapore Pte Ltd 8 Wilkie Road, #07-01 Wilkie Edge, Singapore 228095
